These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 16227150
1. PD-1/PD-L pathway and autoimmunity. Okazaki T, Wang J. Autoimmunity; 2005 Aug; 38(5):353-7. PubMed ID: 16227150 [Abstract] [Full Text] [Related]
2. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH. J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943 [Abstract] [Full Text] [Related]
4. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation. Currie AJ, Prosser A, McDonnell A, Cleaver AL, Robinson BW, Freeman GJ, van der Most RG. J Immunol; 2009 Dec 15; 183(12):7898-908. PubMed ID: 20007574 [Abstract] [Full Text] [Related]
5. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Carreno BM, Collins M. Annu Rev Immunol; 2002 Dec 15; 20():29-53. PubMed ID: 11861596 [Abstract] [Full Text] [Related]
6. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA. J Exp Med; 2006 Nov 27; 203(12):2737-47. PubMed ID: 17116737 [Abstract] [Full Text] [Related]
7. The PD-1/PD-Ls pathway and autoimmune diseases. Dai S, Jia R, Zhang X, Fang Q, Huang L. Cell Immunol; 2014 Jul 27; 290(1):72-9. PubMed ID: 24908630 [Abstract] [Full Text] [Related]
8. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Wang L, Han R, Hancock WW. Eur J Immunol; 2007 Oct 27; 37(10):2983-90. PubMed ID: 17899549 [Abstract] [Full Text] [Related]
9. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR. J Immunol; 2008 Aug 15; 181(4):2513-21. PubMed ID: 18684942 [Abstract] [Full Text] [Related]
10. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. J Exp Med; 2003 Jul 07; 198(1):71-8. PubMed ID: 12847138 [Abstract] [Full Text] [Related]
11. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M, Klareskog L, Catrina AI, Sidiropoulos P, Boumpas DT. Arthritis Rheum; 2010 Jul 07; 62(7):1870-80. PubMed ID: 20506224 [Abstract] [Full Text] [Related]
12. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Seko Y, Yagita H, Okumura K, Azuma M, Nagai R. Cardiovasc Res; 2007 Jul 01; 75(1):158-67. PubMed ID: 17434153 [Abstract] [Full Text] [Related]
13. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. Shin T, Kennedy G, Gorski K, Tsuchiya H, Koseki H, Azuma M, Yagita H, Chen L, Powell J, Pardoll D, Housseau F. J Exp Med; 2003 Jul 07; 198(1):31-8. PubMed ID: 12847135 [Abstract] [Full Text] [Related]
15. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Nat Immunol; 2001 Mar 07; 2(3):261-8. PubMed ID: 11224527 [Abstract] [Full Text] [Related]
16. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Sugita S, Usui Y, Horie S, Futagami Y, Aburatani H, Okazaki T, Honjo T, Takeuchi M, Mochizuki M. Invest Ophthalmol Vis Sci; 2009 Jun 07; 50(6):2862-70. PubMed ID: 19182257 [Abstract] [Full Text] [Related]
17. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T, Akiba H, Yagita H, Takahashi Y, Omura K, Okumura K, Azuma M. Eur J Immunol; 2003 Oct 07; 33(10):2773-82. PubMed ID: 14515261 [Abstract] [Full Text] [Related]
18. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome. Kobayashi M, Kawano S, Hatachi S, Kurimoto C, Okazaki T, Iwai Y, Honjo T, Tanaka Y, Minato N, Komori T, Maeda S, Kumagai S. J Rheumatol; 2005 Nov 07; 32(11):2156-63. PubMed ID: 16265694 [Abstract] [Full Text] [Related]
19. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ, Hoogsteden HC, Lambrecht BN. Eur J Immunol; 2006 Sep 07; 36(9):2472-82. PubMed ID: 16917960 [Abstract] [Full Text] [Related]
20. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice. Kasagi S, Kawano S, Okazaki T, Honjo T, Morinobu A, Hatachi S, Shimatani K, Tanaka Y, Minato N, Kumagai S. J Immunol; 2010 Mar 01; 184(5):2337-47. PubMed ID: 20139271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]